Imricor Medical Systems Inc (AU:IMR) — Market Cap & Net Worth
Market Cap & Net Worth: Imricor Medical Systems Inc (IMR)
Imricor Medical Systems Inc (AU:IMR) has a market capitalization of $448.50 Million (AU$633.87 Million) as of May 4, 2026. Listed on the AU stock exchange, this Australia-based company holds position #13120 globally and #339 in its home market, demonstrating a -3.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Imricor Medical Systems Inc's stock price AU$1.98 by its total outstanding shares 320947028 (320.95 Million). Analyse cash efficiency ratio of Imricor Medical Systems Inc to see how efficiently the company converts income to cash.
Imricor Medical Systems Inc Market Cap History: 2019 to 2026
Imricor Medical Systems Inc's market capitalization history from 2019 to 2026. Data shows growth from $271.37 Million to $448.50 Million (4.74% CAGR).
Imricor Medical Systems Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Imricor Medical Systems Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
321.90x
Imricor Medical Systems Inc's market cap is 321.90 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $271.37 Million | $639.70K | -$14.80 Million | 424.22x | N/A |
| 2020 | $513.22 Million | $702.16K | -$13.08 Million | 730.92x | N/A |
| 2021 | $228.23 Million | $696.27K | -$20.56 Million | 327.79x | N/A |
| 2022 | $82.89 Million | $816.01K | -$17.53 Million | 101.58x | N/A |
| 2023 | $129.44 Million | $615.57K | -$22.63 Million | 210.28x | N/A |
| 2024 | $308.84 Million | $959.42K | -$29.69 Million | 321.90x | N/A |
Competitor Companies of IMR by Market Capitalization
Companies near Imricor Medical Systems Inc in the global market cap rankings as of May 4, 2026.
Key companies related to Imricor Medical Systems Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Imricor Medical Systems Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, Imricor Medical Systems Inc's market cap moved from $271.37 Million to $ 448.50 Million, with a yearly change of 4.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$448.50 Million | +29.08% |
| 2025 | AU$347.45 Million | +12.50% |
| 2024 | AU$308.84 Million | +138.60% |
| 2023 | AU$129.44 Million | +56.16% |
| 2022 | AU$82.89 Million | -63.68% |
| 2021 | AU$228.23 Million | -55.53% |
| 2020 | AU$513.22 Million | +89.12% |
| 2019 | AU$271.37 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Imricor Medical Systems Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $448.50 Million USD |
| MoneyControl | $448.50 Million USD |
| MarketWatch | $448.50 Million USD |
| marketcap.company | $448.50 Million USD |
| Reuters | $448.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include… Read more